Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HAINAN POLY

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve CISATRACURIUM BESYLATE

Comment Full text

TEVA PHARMS INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 25
  • 0 comments

FDA approve METOCLOPRAMIDE

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 23
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 38
  • 0 comments

FDA approve EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 32
  • 0 comments

FDA approve SUCCINYLCHOLINE CHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 28
  • 0 comments

FDA approve ROPIVACAINE HYDROCHLORIDE

Comment Full text

LABORATOIRE HRA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 35
  • 0 comments

FDA approve NORGESTREL

Comment Full text

GENUS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve ACETAMINOPHEN; HYDROCODONE BITARTRATE

Comment Full text

BARR LABS INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve IBUPROFEN; OXYCODONE HYDROCHLORIDE

Comment Full text

GENUS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 33
  • 0 comments

FDA approve ACETAMINOPHEN; HYDROCODONE BITARTRATE

Comment Full text
  • Previous
  • 518
  • 519
  • 520
  • 521
  • 522
  • Next

Search

News categories

  • Technical Exchange News(13043)
  • Event(6229)
  • SEC News(322791)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(181805)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin